Drugs / Prevantics Maxi Swabstick
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | PREVANTICS SWABSTICK | — | 2005-06-03 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT03861780 Comparator | Apr → Jun 2019 | — | Professional Disposables International, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT03817580 Comparator | Feb → Jun 2019 | — | Professional Disposables International, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prevantics Maxi Swabstick | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03817580 ↗ |
| Route | Topical | “Application of antiseptic drug to the inguinal and abdomen areas of the subjects” NCT03817580 ↗ |